ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 645991 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 645991; 2) Community: the network communities that were significantly associated with the response to NSC 645991; 3) Molecule: the relationships between components within communities and NSC 645991; 4) MDR: the compounds that were significantly associated with the NSC 645991.

NSC Compound Enrichment Correlation
NSC 244404 Null 0.0385613993886001 0.33977875
NSC 275647 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- 0.0385613993886001 0.41111215
NSC 301457 Cycloalkannin 0.0385613993886001 0.72868744
NSC 335995 Null 0.0385613993886001 0.32291771
NSC 339137 PHYSALOLACTONE 0.0385613993886001 0.41135468
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.0385613993886001 0.34333344
NSC 372155 2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- 0.0385613993886001 0.64758807
NSC 39215 Null 0.0385613993886001 0.43210496
NSC 603578 Platinum, tetrachloro[dimethylsilylenebis(methanamine)]-, (OC-6-22) 0.0385613993886001 0.4168727
NSC 606497 Camptothecin Derivative 0.0385613993886001 0.1482489
Total:113  Current:82    [First] [Prev] [Next] [Last]